ACTIVE

ReGenesys

Export PDF

Financial year 2021 · Closed on 31/12/2021

Net result-3 M €-54,3 %over 1 year

Revenue1 M €-12,6 %over 1 year

Equity-5 M €-135,9 %over 1 year

Workforce13,2 ETP-6,4 %over 1 year

Identity

Source · BCE/KBO

ReGenesys is a Private limited company incorporated in 2005. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven. It employs on average 13,2 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0877.070.337
Incorporation: 03/11/2005
Legal form: Private limited company
Registered office: Gaston Geenslaan 1
3001 Leuven · FlandreSee on map
Contributed capital: 1 000 000,00 €
Latest accounts: 31/12/2021
Average workforce: 13,2 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology

Joint committees (2)

Signals

Healthy social debtsHigh revenue

Financials

Source · NBB, 16 filings

Trend over 14 financial years

	2021		2018		2017		2016		2015
Income statement
Revenue	1 M €	-12.6%	1,1 M €	+27.3%	902,4 k €	+22.9%	734,3 k €	-23.8%	964,2 k €
EBITDA	-2,6 M €	-78.9%	-1,5 M €	+1.8%	-1,5 M €	+2.1%	-1,5 M €	-21.1%	-1,3 M €
Operating result	-2,8 M €	-44.7%	-2 M €	+9.4%	-2,2 M €	-4.8%	-2,1 M €	-12.9%	-1,8 M €
Net result	-3 M €	-54.3%	-1,9 M €	+7.4%	-2,1 M €	-9.1%	-1,9 M €	-14.8%	-1,7 M €
Balance sheet
Equity	-5 M €	-136%	-2,1 M €	-1385%	-143,7 k €	+89.5%	-1,4 M €	-511%	332,9 k €
Total assets	637,3 k €	-67.0%	1,9 M €	-28.9%	2,7 M €	-11.9%	3,1 M €	+18.6%	2,6 M €
Cash	115,6 k €	-49.4%	228,4 k €	-69.4%	746,2 k €	+235%	222,9 k €	-63.6%	611,7 k €
Debts	5,6 M €	+40.6%	4 M €	+55.1%	2,6 M €	-38.2%	4,2 M €	+87.7%	2,2 M €
Other
Workforce	13,2 ETP	-6.4%	14,1 ETP	+5.2%	13,4 ETP	-1.5%	13,6 ETP	-3.5%	14,1 ETP

Board of directors

Source · NBB, accounts to 31/12/2021

3 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Dan Camardo	Directorsince 01/06/2022
Ivor Macleod	Director15/02/2021 → 01/06/2022
William Otto Lehmann Jr.	Director27/10/2005 → 01/06/2022

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CellAR0810.901.192Represented by Jozef PINXTEREN	Manager05/03/2010 → 2015 accounts
Gil Bradford Van Bokkelen	Director27/10/2005 → 2020 accounts

Other companies at this address

Gaston Geenslaan 1 3001 Leuven

Company	CBE no.
Bio-Incubator Leuven● Active	0876.605.232
Community Building Arenberg● Active	1014.096.594
Creative Biolabs Belgium● Active	1028.942.544
DName-iT● Active	0506.754.823
Fisherman● Active	0804.287.079
Fishway● Active	0787.869.632
Formac Pharmaceuticals● Active	0892.914.395
IDA INTERNATIONAL● Active	1002.119.470
Lever Bio Belgium● Active	1039.455.958
Maatschap reMYND● Active	1019.655.090
miDiagnostics● Active	0641.984.602
Oxurion● Active	0881.620.924
PALEO● Active	0756.986.614
PARKEERGEBOUW● Active	1009.039.728
Pledge Therapeutics● Active	0726.743.301
Qmineral● Active	0837.633.897
Raya Therapeutic● Active	1003.128.171
ReGenesys EU● Active	0544.577.301
reMYND● Active	0476.910.101
ReWrite● Active	1016.891.283

Full financial information

Source · NBB

	2021	2020	2019	2018	2017	2016
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017	01/01/2016
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017	31/12/2016
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	26/09/2023	11/08/2021	30/07/2020	30/07/2019	20/08/2018	28/07/2017
General meeting	11/08/2023	30/06/2021	30/06/2020	28/06/2019	29/06/2018	30/06/2017
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2021	11/08/2023	26/09/2023	Dutch	PDF
Full model	31/12/2020	30/06/2021	11/08/2021	Dutch	PDF
Full model	31/12/2019	30/06/2020	30/07/2020	Dutch	PDF
Full model	31/12/2018	28/06/2019	30/07/2019	Dutch	PDF
Full model	31/12/2017	29/06/2018	20/08/2018	Dutch	PDF
Full model	31/12/2016	30/06/2017	28/07/2017	Dutch	PDF
Full model	31/12/2015	30/09/2016	27/10/2016	Dutch	PDF
Full model	31/12/2014	21/08/2015	27/08/2015	Dutch	PDF
Full model	31/12/2013	30/06/2014	15/07/2014	Dutch	PDF
Full model	31/12/2012	17/06/2013	28/06/2013	Dutch	PDF
Full model	31/12/2011	07/09/2012	28/09/2012	Dutch	PDF
Full model	31/12/2010	30/06/2011	01/09/2011	Dutch	PDF
Full model	31/12/2009	30/06/2010	08/07/2010	Dutch	PDF
Full model	31/12/2008	30/06/2009	28/08/2009	Dutch	PDF
Full model	31/12/2007	30/06/2008	23/07/2008	Dutch	PDF
Full model	31/12/2006	15/06/2007	10/07/2007	Dutch	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2021

3 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Dan Camardo	Directorsince 01/06/2022
Ivor Macleod	Director15/02/2021 → 01/06/2022
William Otto Lehmann Jr.	Director27/10/2005 → 01/06/2022

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CellAR0810.901.192Represented by Jozef PINXTEREN	Manager05/03/2010 → 2015 accounts
Gil Bradford Van Bokkelen	Director27/10/2005 → 2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates30/06/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/05/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/03/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/03/2020
ONTSLAGEN - BENOEMINGEN
PDF
Other09/01/2020
WIJZIGING RECHTSVORM
PDF
Mandates21/11/2019
ONTSLAGEN - BENOEMINGEN
PDF
Other31/01/2018
DIVERSEN
PDF
Capital / shares17/01/2018
Kapitaalverhoging - Kapitaalvermindering - Statutenwijziging - Volmacht
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings14 filings

Mandates

Dan Camardo

Ivor Macleod

William Otto Lehmann Jr.

CellAR

William Otto Lehmann JR

William Otto Lehmann Junior

Lehmann William Otto

Gil Bradford Van Bokkelen

2005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

ReGenesys

Gaston Geenslaan 1, 3001 Heverlee

Director

Manager

DirectorManager

Manager

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Gaston Geenslaan 1, 3001 HeverleeCurrent	accounts 2021	Accounts 2021 · 2023-00456397

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
ReGenesysCurrent	accounts 2006 → 2021	Accounts 2021 · 2023-00456397

Events

2021
Annual accounts 2021-3 M €↓
2018
Annual accounts 2018-1,9 M €↑
2017
Annual accounts 2017-2,1 M €↓
2016
Annual accounts 2016-1,9 M €↓
2015
Annual accounts 2015-1,7 M €↓
2014
Annual accounts 2014-1,6 M €↓
2013
Annual accounts 2013-1,5 M €↑
2012
Annual accounts 2012-2,1 M €↓
2011
Annual accounts 2011-2 M €↓
2010
Annual accounts 2010-928,1 k €↓
2009
Annual accounts 2009-212,2 k €↑
2008
Annual accounts 2008-237,2 k €↓
2007
Annual accounts 2007-209 k €↓
2006
Annual accounts 2006-2,8 k €
03/11/2005
IncorporationPrivate limited company

ReGenesys

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events